期刊文献+

E-钙黏蛋白和N-钙黏蛋白启动子的构建及活性测定 被引量:1

Construction and activity characterization of E-cadherin and N-cadherin promoters
原文传递
导出
摘要 目的构建含有E-钙黏蛋白(cadherin)基因和N-钙黏蛋白基因启动子的荧光素酶报告基因载体,并检测E-钙黏蛋白启动子和N-钙黏蛋白启动子的活性。方法利用PCR技术从乳腺癌细胞ZR75-1基因组中扩增出E-钙黏蛋白和N-钙黏蛋白启动子片段,插入到荧光素酶报告基因载体p GL4-basic中,确定所扩增的DNA序列后,将其转染至乳腺癌细胞ZR75-1和肝癌细胞Hep G2中,检测启动子的活性。结果测序结果表明,扩增的E-钙黏蛋白启动子序列正确;荧光素酶活性实验表明,E-钙黏蛋白启动子和N-钙黏蛋白启动子在乳腺癌细胞ZR75-1和肝癌细胞Hep G2中表达都具有活性。结论成功构建了E-钙黏蛋白启动子和N-钙黏蛋白启动子报告基因表达载体,为进一步筛选调节E-钙黏蛋白和N-钙黏蛋白表达的转录因子提供了重要基础。 Objective To clone E-cadherin and N-cadherin promoters and insert them into a luciferase reporter gene vector, and to characterize the promoter activity of E-cadherin and N-cadherin. Methods E-cadherin and N-cadherin pro- moter were cloned into pGIA-basie. The resulting plasmids were determined by DNA sequencing. The promoter activity was analyzed in breast cancer cell line ZR75-1 and hepatocareinoma cell line HepG2. Results DNA sequencing showed that the sequences of the cloned promoter regions were correct. Analysis of the reporter gene activity indicated that the E-cad- herin and N-cadherin promoters had the highest transcriptional activity in ZR75-1 and HepG2 cells. Conclusion The E- cadherin and N-cadherin promoter genes are cloned successfully, contributing much to screening transcription factors that regulate E-cadherin and N-cadherin expression.
出处 《军事医学》 CAS CSCD 北大核心 2014年第11期860-862,共3页 Military Medical Sciences
基金 国家自然科学基金资助项目(31071174,81272231) 北京科技新星资助项目(2011112)
关键词 E-钙黏蛋白 N-钙黏蛋白 启动子 荧光素酶报告基因 E-cadherin N-cadherin promoter luciferase reporter gene
  • 相关文献

参考文献16

  • 1Christiansen JJ, Rajasekaran AK. Reassessing epithelial to mes- enchymal transition as a prerequisite for carcinoma invasion and metastasis[ J]. Cancer Res, 2006, 66(17) :8319 - 8326.
  • 2Klymkowsky MW, Savagner P. Epithelial-mesenchymal tran- sition: a cancer researcher's conceptual friend and foe[ J]. Am J Pathol, 2009,174(5) :1588 - 1593.
  • 3王瑜,付洁,程龙,徐小洁,宋海峰,叶棋浓.靶向FHL1的microRNA初步筛选研究[J].军事医学,2013,37(6):423-426. 被引量:2
  • 4刘婕,林娅红,张亚楠,丁丽华,叶棋浓.VEGF启动子活性的测定[J].军事医学,2013,37(3):184-186. 被引量:2
  • 5Hay ED. An overview of epithelio-mesenchymal transformation [ J]. Acta Anat, 1995, 154 ( 1 ) :8 - 20.
  • 6L6pez-Novoa JM, Nieto MA. Inflammation and EMT : an alliance towards organ fibrosis and cancer progression [J]. EMBO Mol Med,2009, 1 (6 -7) :303 -314.
  • 7Savagner P. The epithelial-mesenchymal transition (EMT) phe- nomenon[J]. Ann Oncol, 2020, 21(7) :89 -92.
  • 8Vandewa/le C, Comijn J, De Craene B, et al. SIP1/ZEB2 in- duces EMT by repressing genes of different epithelial cell-cell junctions[J]. Nucleic Acids Res, 2005, 33(20) :6566 -6578.
  • 9Wheeloek MJ, Shintani Y, Maeda M, et al. Cadherin switching[J]. JCellSci, 2008, 121(6) :727 -735.
  • 10Yap AS, Crampton MS, Hardin J. Making and breaking contacts the cellular biology of cadherin regulation [ J ]. Curt Opln Cell Biol,2007,19(5) :508 -524.

二级参考文献30

  • 1Vamesu S. Angiogenesis and tumor histologic type in primarybreast cancer patients: an analysis of 155 needle core biopsies[J]. Rom J Morphol Embryol,2008 , 49(6) : 181 - 188.
  • 2Szabo S, Khomenko T, Gombos Z , et al. Review article :transcription factors and growth factors in ulcer healings [ J ].Aliment Pharmacol Ther, 2000,14( 1) : 33 -43.
  • 3Liang Y, Brekken RA, Hyder SM. Vascular endothelial growthfactor induces proliferation of breast cancer cells and inhibits theanti-proliferative activity of anti-hormones [ J ]. Endocr RelatCancer,2006,13(3) :905 -919.
  • 4Cascio S, D,Andrea A, Ferla R,et al. miR-20b Modulates VEGFexpression by targeting HIF-1 alpha and STAT3 in mcf-7 breastcancer cells[ J]. J Cell Physiol,2010 , 224( 1) :242 - 249.
  • 5Jadwiga J, Michal M. Transcription factors having impact on vas-cular endothelial growth factor ( VEGF) gene expression in angio-genesis [J]. Med Sci Monit, 2004,10(4) : RA89 -98.
  • 6Coultas L, Chawengsaksophak K, Rossant J. Endothelial cellsand VEGF in vascular development [ J ]. Nature,2005,438.7070) :937 -945.
  • 7Xie KP,Wei DY, Shi Q,et al. Constitutive and inducible ex-pression and regulation of vascular endothelial growth factor[ J].Cytokine Growth Factor Rev, 2004,15 (5) : 297 -324.
  • 8Lin J, Qin X,Ye Q,ei al. FHL family members suppress vascu-lar endothelial growth factor expression through blockade [ J ].IUBMB Life,2012,64(11) :921 -930.
  • 9Dong W,Li Y, Song L,et al^IKKa contributes to UVB-inducedVEGF expression by regulating AP-1 transactivation[ J]. NucleicAcids Res,2012,40(7) :2940 -2955.
  • 10Na HK, Kim EH. Surh YJ, et al. Diallyl trisulfide induces ap-optosis in human breast cancer cells through ROS-mediated acti-vation of JNK and AP-1 [ J]. Biochem Pharmacol,2012,84(10):1241 -1250.

共引文献2

同被引文献4

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部